Radiofrequency Catheter Ablation (RFCA) as second-line ... - NHS

30. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, et al. Circumferentialpulmonary-vein ablation for chronic atrial fibrillation. New England Journal of Medicine.2006;354(9):934-41.31. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, et al. Catheterablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multicentre,randomized, controlled study (Catheter Ablation For The Cure Of AtrialFibrillation Study). European Heart Journal. 2006;27(2):216-21.32. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomaticatrial fibrillation - A randomized trial. Jama-Journal of the American Medical Association.2005;293(21):2634-40.33. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. Arandomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drugtherapy in paroxysmal atrial fibrillation - The APAF study. Journal of the AmericanCollege of Cardiology. 2006;48(11):2340-7.34. Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C,Pooranawattanakul S, Punlee K, et al. A randomized clinical trial of the efficacy ofradiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrialfibrillation. J Med Assoc Thai. 2003;86 Suppl 1:S8-16.35. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter AblationVersus Antiarrhythmic Drugs for Atrial Fibrillation The A4 Study. Circulation.2008;118(24):2498-505.36. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. Acomparison of rate control and rhythm control in patients with atrial fibrillation. NewEngland Journal of Medicine. 2002;347(23):1825-33.37. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al.Relationships between sinus rhythm, treatment, and survival in the atrial fibrillationfollow-up investigation of rhythm management (AFFIRM) study. Circulation.2004;109(12):1509-13.38. Moyle GJ. Truth, lies, and statistical tests. AIDS Read. 2003;13(3):117-8, 23-4, 26.39. Lamotte M, Annemans L, Bridgewater B, Kendall S, Siebert M. A health economicevaluation of concomitant surgical ablation for atrial fibrillation. European Journal ofCardio-Thoracic Surgery. 2007;32:702-10.40. McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S, et al. Costeffectivenessof radiofrequency catheter ablation for the treatment of atrial fibrillation inthe United Kingdom. Heart (London). 2009;95(7):542-9.41. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR. Costcomparison of catheter ablation and medical therapy in atrial fibrillation. Journal ofCardiovascular Electrophysiology. 2007;18(9):907-13.42. Khaykin Y, Wang XY, Natale A, Wazni OM, Skanes AC, Humphries KH, et al. CostComparison of Ablation Versus Antiarrhythmic Drugs As First-Line Therapy for AtrialFibrillation: An Economic Evaluation of the RAAFT Pilot Study. Journal of CardiovascularElectrophysiology. 2009;20(1):7-12.Dr Lauren Ahyow. RFCA for the treatment of atrial fibrillation. August 2010. 17